317: I Was Wrong About Wegovy, Ozempic, and Mounjaro with Dr. Taylor Brueseke
Biceps After Babies Radio
00:00
Exploring Medications for Weight Loss and Diabetes
The chapter delves into the drugs Ozempic and Monjaro, both containing semiglutide, manufactured by Novo Nordisk for various health purposes. It discusses the similarity between these medications and Terzepatide from Eli Lilly, focusing on FDA indications for weight loss, obesity, and diabetes. The conversation also explains the mechanism of action of GLP-1 agonists like Ozempic in stimulating feelings of fullness to aid in weight loss.
Transcript
Play full episode
